Talk Title: Delivery of Ocular Gene Therapy. Next Steps in Access for Patients

Prof Keegan is the lead for Ireland’s consortium to the European Reference Network for Rare Eye Disease (ERN-EYE Ireland Consortium:- EEIC) and The Pan European ERN EYE rare Eye Disease Registry (REDgistry)

Regional Clinical Eye Care Transformation Lead North East Ireland

Clinical Lead for Target 5000 (The All-Ireland Inherited Retinal Degeneration Programme)

He runs the Mater Retina Research Group and their interests include Inherited Retinal Disease, Macular Degeneration (Biomarkers and Low vision devices), Diabetic retinopathy, Artificial Intelligence and Enhanced Imaging.

He and his team performed the first Ocular Gene Therapy in Ireland at the Mater in Nov 2024

MB BCh BAO; LRCP&SI. MMedSc (Anat); FRCSI(Oph); FRCOphth; PhD

National Clinical Lead for Diabetic Retinopathy Screening and Treatment in Ireland (Diabetic RetinaScreen)

Consultant Retinal Surgeon at Mater Hospital

UCD Clinical Professor of Ophthalmology and Retina, UCD School of Medicine, University College Dublin